Biden administration invests $48M in AI/ML platform to identify rare disease drugs
The Biden administration is doling out $48 million to a nonprofit that wants to use machine learning and artificial intelligence to identify potential rare disease …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.